Solara Active Pharma Sciences Ltd (NSE:SOLARA) Share Price

Company Profile

Business description
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
Contact
Phase II - CSIR Road
Module No. 601, 602, 603, Ticel Bio Park
Taramani
ChennaiTN600113
IND
T: +91 4447406200
https://www.solara.co.in
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
2,924

Recommended

Even as competition looks likely to build, the company remains a leading wide-moat business securely at the center of the AI ecosystem.

Brian Colello, CPA | 19 June 2026

Most Australians will end up owning SpaceX — whether they like it or not.

Tyger Fitzpatrick | 19 June 2026

Investors are raising concerns about the future of telecommunication connectivity in Australia.

Brian Han | 17 June 2026

Index	Last price	Change	% Change
All Ordinaries	9,050.20	23.00	-0.25%
CAC 40	8,467.98	37.19	0.44%
DAX 40	25,026.80	92.13	0.37%
Dow JONES (US)	51,564.70	72.15	0.14%
FTSE 100	10,399.70	108.91	-1.04%
HKSE	23,924.81	387.35	-1.59%
NASDAQ	26,517.93	496.28	1.91%
Nikkei 225	71,644.53	591.04	0.83%
NZX 50 Index	13,415.34	52.03	0.39%
S&P 500	7,500.58	80.48	1.08%
S&P/ASX 200	8,831.30	25.30	-0.29%
SSE Composite Index	4,090.48	17.59	-0.43%